Northwest Biotherapeutics Inc Sample Contracts
EXHIBIT 10.27 NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR...Warrant Agreement • April 18th, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
COMMON STOCK PURCHASE WARRANT northwest biotherapeutics, inc.Security Agreement • October 10th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ______________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October __, 2014 (the “Issuance Date”) and on or prior to the close of business on October __, 2017 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NORTHWEST BIOTHERAPEUTICS, INC., a Delaware corporation (the “Company”), up to _________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock; provided, however, to the extent that a resale registration statement registering all of the Warrant Shares (the “Resale Registration Statement”) is not filed within 30 days of the Issuance Date, is not declared effective within 90 days of the Issuance Date or is suspended for any reason thereafter prior to the Termination Date, the Termination Date shall be extended by an equ
FORM OF COMMON STOCK PURCHASE WARRANT CLASS D-3 NORTHWEST BIOTHERAPEUTICS, INC.Common Stock Purchase Warrant • June 28th, 2018 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _______, 2020 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 22nd, 2017 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 20, 2017, between Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 10.2 FORM OF WARRANT THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR WITH ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD...Warrant Agreement • March 31st, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENT UNDERWRITING AGREEMENTUnderwriting Agreement • October 10th, 2001 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 19th, 2016 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
This Agreement is made pursuant to the certain letter agreement, dated as of the date hereof, between the Company and each Purchaser (the “Letter Agreement”).
EXHIBIT 10.1 SETTLEMENT AGREEMENT This Settlement Agreement (this "Agreement") is made effective as of June 30, 2003, by and between NEXUS CANYON PARK LLC, a Delaware limited liability company ("Nexus" or "Landlord"), and NORTHWEST BIOTHERAPEUTICS,...Settlement Agreement • August 14th, 2003 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
UNDERWRITING AGREEMENT between NORTHWEST BIOTHERAPEUTICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters NORTHWEST BIOTHERAPEUTICS, INC.Underwriting Agreement • December 4th, 2012 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
The undersigned, Northwest Biotherapeutics, Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Northwest Biotherapeutics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis Capital Corp. (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
EXHIBIT 10.3 NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR...Warrant Agreement • November 14th, 2003 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
RECITALS:Security Agreement • November 14th, 2003 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 23rd, 2017 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March [__], 2017, between Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
BETWEENSublease Agreement • October 10th, 2001 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
NORTHWEST BIOTHERAPEUTICS, INC., and The Bank of New York Mellon, as Trustee INDENTURE Dated as of August 19, 2014 5.00% Convertible Senior Notes due 2017Indenture • August 25th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of August 19, 2014, between Northwest Biotherapeutics, Inc., a Delaware corporation, as issuer (hereinafter sometimes called the “Company”, as more fully set forth in Section 1.01), and The Bank of New York Mellon, a national banking association, as trustee (hereinafter sometimes called the “Trustee”, as more fully set forth in Section 1.01).
EXHIBIT 10.4 EMPLOYMENT AGREEMENT This Employment Agreement (this "Agreement"), dated as of April 19, 2001, and effective as of February 2, 2001 (the "Effective Date"), is made and entered into by and between Northwest Biotherapeutics, Inc., a...Employment Agreement • August 13th, 2001 • Northwest Biotherapeutics Inc • Textile mill products
CLASS A COMMON STOCK PURCHASE WARRANT NORTHWEST BIOTHERAPEUTICS, INC.Warrant Agreement • March 23rd, 2017 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
THIS CLASS A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time after the Issue Date set forth above (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
LEASE AGREEMENT (CONTINUED)Lease Agreement • April 18th, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
RECITALSSecurities Purchase Agreement • March 31st, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
EXECUTION VERSION EXHIBIT ESubordination Agreement • May 14th, 2004 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
WARRANTWarrant Agreement • April 18th, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
1 EXHIBIT 10.20 NORTHWEST BIOTHERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENTInvestors' Rights Agreement • October 10th, 2001 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
WARRANTWarrant Agreement • December 30th, 2004 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
COMMON STOCK PURCHASE WARRANT northwest biotherapeutics, inc.Common Stock Purchase Warrant • December 29th, 2015 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June __, 2016 (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
BACKGROUNDDevelopment Agreement • August 13th, 2001 • Northwest Biotherapeutics Inc • Textile mill products • Washington
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 14th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 9, 2014, between Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), and the purchaser identified on the signature page hereto (including its successors and assigns, the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 22nd, 2013 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 17, 2013, between Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
ANDSublicense Agreement • October 24th, 2001 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
RECITALSRecapitalization Agreement • November 14th, 2005 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
WARRANTWarrant Agreement • June 21st, 2005 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
SERIES E COMMON STOCK PURCHASE WARRANT northwest biotherapeutics, inc.Common Stock Purchase Agreement • September 19th, 2016 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
THIS SERIES E COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February __, 2016 (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
WARRANTWarrant Agreement • February 1st, 2005 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
FIRST AMENDMENT TO WARRANTSWarrant Amendment • February 1st, 2005 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
STANDBY EQUITY PURCHASE AGREEMENTStandby Equity Purchase Agreement • March 31st, 2025 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
THIS STANDBY EQUITY PURCHASE AGREEMENT (this “Agreement”) dated as of December 19, 2024, is made by and between YA II PN, LTD., a Cayman Islands exempt limited company (the “Investor”), and NORTHWEST BIOTHERAPEUTICS, INC., a company incorporated under the laws of the State of Delaware (the “Company”). The Investor and the Company may be referred to herein individually as a “Party” and collectively as the “Parties.”
COMMON STOCK PURCHASE WARRANT NORTHWEST BIOTHERAPEUTICS, INC.Common Stock Purchase Warrant • July 11th, 2016 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date and on or prior to the close of business on the five year anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EXHIBIT 10.2 INDUSTRIAL LEASE - MULTIPLE TENANT THIS LEASE AGREEMENT made this 18th day of June, 2003, by and between Benaroya Capital Company, LLC, a Washington limited liability company (the "Lessor") and Northwest Biotherapeutics, Inc., a Delaware...Industrial Lease • August 14th, 2003 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington